X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1525) 1525
life sciences & biomedicine (1412) 1412
humans (1317) 1317
animals (641) 641
oncology (610) 610
hematology (560) 560
mice (442) 442
leukemia (437) 437
chronic myeloid leukemia (361) 361
hemic and lymphatic diseases (355) 355
immunology (348) 348
female (344) 344
male (334) 334
leukemia, myelogenous, chronic, bcr-abl positive - genetics (309) 309
bcr (306) 306
leukemia, myelogenous, chronic, bcr-abl positive - pathology (297) 297
signal transduction (280) 280
cell biology (275) 275
apoptosis (273) 273
research (266) 266
fusion proteins, bcr-abl - genetics (265) 265
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (261) 261
middle aged (242) 242
cancer (231) 231
biochemistry & molecular biology (224) 224
adult (220) 220
kinases (219) 219
genetic aspects (218) 218
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (211) 211
gene expression (198) 198
tyrosine (197) 197
mutation (186) 186
b-lymphocytes - immunology (182) 182
imatinib mesylate (181) 181
cell line, tumor (180) 180
bcr protein (172) 172
fusion proteins, bcr-abl - metabolism (171) 171
stem cells (162) 162
proteins (161) 161
bcr-abl (157) 157
aged (156) 156
flow cytometry (154) 154
care and treatment (145) 145
phosphorylation (145) 145
analysis (144) 144
antineoplastic agents - therapeutic use (143) 143
benzamides (142) 142
apoptosis - drug effects (141) 141
b-lymphocytes - metabolism (140) 140
b cells (139) 139
pyrimidines - pharmacology (139) 139
receptors, antigen, b-cell - metabolism (138) 138
antineoplastic agents - pharmacology (135) 135
imatinib (134) 134
cell proliferation (128) 128
protein kinase inhibitors - pharmacology (127) 127
health aspects (125) 125
bone marrow (123) 123
protein kinase inhibitors - therapeutic use (118) 118
lymphocytes b (117) 117
research article (117) 117
physiological aspects (116) 116
leukemia, myelogenous, chronic, bcr-abl positive - immunology (114) 114
philadelphia chromosome (114) 114
multidisciplinary sciences (113) 113
protein-tyrosine kinase (113) 113
science & technology - other topics (113) 113
k562 cells (112) 112
cml (108) 108
fusion protein (108) 108
myeloid leukemia (108) 108
precursor cell lymphoblastic leukemia-lymphoma - genetics (106) 106
cell line (104) 104
b-cell receptor (103) 103
pyrimidines - therapeutic use (102) 102
tumor cells, cultured (101) 101
medicine (100) 100
medicine, research & experimental (100) 100
research & experimental medicine (100) 100
antigens (98) 98
neoplasms (97) 97
development and progression (96) 96
piperazines - pharmacology (95) 95
abl protein (94) 94
adolescent (93) 93
receptors, antigen, b-cell - immunology (93) 93
lymphomas (90) 90
signal transduction - drug effects (90) 90
genetics & heredity (88) 88
cell proliferation - drug effects (87) 87
medicine & public health (87) 87
abridged index medicus (85) 85
cells, cultured (85) 85
genes (85) 85
mice, inbred c57bl (83) 83
t cells (83) 83
prognosis (82) 82
tumors (82) 82
immunoglobulins (81) 81
protein-tyrosine kinases - antagonists & inhibitors (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1899) 1899
Chinese (6) 6
Japanese (6) 6
French (4) 4
Norwegian (3) 3
Czech (1) 1
German (1) 1
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 0028-0836, 05/2015, Volume 521, Issue 7552, pp. 357 - 361
B cells are selected for an intermediate level of B-cell antigen receptor (BCR) signalling strength... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Protein-Tyrosine Kinases - metabolism | Receptors, Antigen, B-Cell - deficiency | Humans | Precursor Cells, B-Lymphoid - metabolism | Inositol Polyphosphate 5-Phosphatases | Intracellular Signaling Peptides and Proteins - metabolism | Precursor Cells, B-Lymphoid - drug effects | Receptors, Antigen, B-Cell - metabolism | Antigens, CD - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor Cells, B-Lymphoid - pathology | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Gene Deletion | Female | B-Lymphocytes - pathology | Cell Death - drug effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Syk Kinase | B-Lymphocytes - metabolism | Disease Models, Animal | Phosphoric Monoester Hydrolases - antagonists & inhibitors | Enzyme Activation - drug effects | Mice, SCID | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Xenograft Model Antitumor Assays | B-Lymphocytes - drug effects | Fusion Proteins, bcr-abl - genetics | Tyrosine - metabolism | Animals | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - metabolism | Signal Transduction - drug effects | Cell Transformation, Neoplastic | Intracellular Signaling Peptides and Proteins - agonists | Cell Line, Tumor | Mice, Inbred NOD | Receptors, Antigen, B-Cell - genetics | Mice | Amino Acid Motifs - genetics | Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | Phosphoric Monoester Hydrolases - metabolism | Receptors, Immunologic - genetics | Protein Tyrosine Phosphatase, Non-Receptor Type 6 - deficiency | Receptors, Immunologic - metabolism | Drug Resistance, Neoplasm - drug effects | Physiological aspects | Acute lymphocytic leukemia | B cells | Signal transduction | Rodents | Leukemia | Mutation | Drug resistance | Kinases | Cells | Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 03/2019, Volume 25, Issue 5, pp. 1574 - 1587
Journal Article
Cytokine & growth factor reviews, ISSN 1359-6101, 06/2013, Volume 24, Issue 3, pp. 203 - 215
...). This often leads to the assumption that BAFF is mostly a B cell factor with a specific role in autoimmunity... 
Advanced Basic Science | Autoimmunity | B cell activating factor from the tumor necrosis factor family (TNF) (BAFF) | Systemic lupus erythematosus (SLE) | A proliferation inducing ligand (APRIL) | Cancer | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | B-Cell Activating Factor - physiology | Antibodies, Monoclonal, Humanized - therapeutic use | Asthma - physiopathology | B-Cell Maturation Antigen - physiology | Humans | Recombinant Fusion Proteins - therapeutic use | Tumor Necrosis Factor Ligand Superfamily Member 13 - physiology | Antibodies, Monoclonal - therapeutic use | Transplantation Immunology - physiology | Clinical Trials as Topic | Transmembrane Activator and CAML Interactor Protein - physiology | Bacterial Infections - physiopathology | Animals | B-Lymphocytes - immunology | Virus Diseases - physiopathology | Autoimmunity - immunology | Graft vs Host Disease - physiopathology | Lupus Erythematosus, Systemic - drug therapy | Parasitic Diseases - physiopathology | Cells | Systemic lupus erythematosus | ICOS, inducible costimulatory | ANA, anti-nuclear autoantibodies | BCMA, B cell maturation antigen | PC, plasma cell | SCF, stem cell factor | SLE, systemic lupus erythematosus | BAFF-R, BAFF-receptor | BCR, B cell receptor | DCs, dentritic cells | EULAR, European League Against Rheumatism | BAFF, B cell activating factor from the TNF family | PFS, progression-free survival | mRNA, messenger ribonucleic acid | BOS, bronchiolitis obliterans syndrome | TLR, toll-like receptor | HSCT, hematopoietic stem cell transplantation | HIV, human immunodeficiency virus | TNF, tumor necrosis factor | NgR, Nogo-66 receptor | SAEs, serious adverse events | NZW, New-Zealand white | NK, natural killer | CLL, chronic lymphocytic leukemia | IL, interleukin | GC, germinal center | EBV, Epstein–Barr virus | Th, T-helper | MMF, mycophenolate mofetil | ALL, acute lymphoblastic leukemia | MyD88, myeloid differentiation primary response gene 88 | SLEDAI, SLE Disease Activity Index | cGVHD, chronic graft versus host disease | CIDP, chronic-inflammatory demyelinating polyneuropathy | APRIL, a proliferation inducing ligand | dsDNA, double stranded deoxyribonucleic acid | TACI, transmembrane activator and cyclophilin ligand interactor | SS, Sjögren's syndrome | MTX, methotrexate | MVECS, microvacular endothelial cells | IFN, interferon | Treg, regulatory T cells | Ig, immunoglobulin | FDA, Food and Drug Administration | HSPGs, heparan sulfate proteoglycans | MS, multiple sclerosis | NZB, New-Zealand black | SNPs, single nucleotide polymorphisms | MZ, marginal zone | CNS, central nervous system | CVID, common variable immunodeficiency | TGF-β, transforming growth factor-β | ECP, extracorporeal photopheresis | RF, rheumatoid factor | ACR, American College of Rheumatology | Tg, transgenic | LN, lupus nephritis | RSV, respiratory syncytial virus
Journal Article